O6-methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia

Anticancer Res. 1991 Jan-Feb;11(1):115-21.

Abstract

Using L1210 and a subline resistance to chloroethylnitrosoureas (L1210/BCNU), we found that the resistance to 1-(2-chloroethyl)-1-nitrosourea (CNU) or to diethyl-1-3-(2-chloroethyl)-3-nitrosoureido ethyl phosphonate (fotemustine) can be reversed by a pretreatment with O6-methyl Guanine (O6-mGua) or temozolomide. In L1210/BCNU but not in L1210 the pretreatment with O6mGua caused an increased peak level of CNU-induced DNA-interstrand crosslinks. We then evaluated whether the resistance to BCNU could be counteracted in vivo by i.p. O6mGua treatment of L1210/BCNU bearing mice. The results were negative due to the fact that O6mGua, which was not toxic when given alone, caused a high toxicity when associated with BCNU.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Carmustine / pharmacology*
  • Carmustine / therapeutic use
  • Cell Cycle / drug effects
  • Cell Division / drug effects
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / pharmacology
  • Dacarbazine / therapeutic use
  • Drug Evaluation, Preclinical
  • Drug Resistance
  • Ethylnitrosourea / analogs & derivatives*
  • Ethylnitrosourea / pharmacology
  • Ethylnitrosourea / therapeutic use
  • Guanine / analogs & derivatives*
  • Guanine / pharmacology
  • Guanine / therapeutic use
  • Kinetics
  • Leukemia L1210 / drug therapy*
  • Mice
  • Mice, Inbred DBA
  • Nitrosourea Compounds / pharmacology*
  • Nitrosourea Compounds / therapeutic use
  • Organophosphorus Compounds / pharmacology*
  • Organophosphorus Compounds / therapeutic use
  • Temozolomide

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • 1-(2-chloroethyl)-1-nitrosourea
  • Guanine
  • Dacarbazine
  • O-(6)-methylguanine
  • fotemustine
  • Ethylnitrosourea
  • Carmustine
  • Temozolomide